Qure.ai

Qure.ai is an enterprise-grade medical intelligence platform that utilizes deep-learning technology to automate the interpretation of diagnostic imaging. By analyzing complex data streams from chest X-rays, CT scans, and point-of-care ultrasounds, the system assists radiologists, emergency physicians, and public health workers in detecting critical abnormalities within seconds. The platform aims to bridge the global gap in specialist availability, streamline diagnostic workflows, and significantly reduce time-to-treatment for both acute medical emergencies and long-term disease management.

The platform is organized into highly specialized, modality-focused modules that cater to distinct clinical pathways. The foundational chest radiography module is qXR, which handles multi-indication chest X-ray screening, identifies automated indicators for heart failure, and supports early, automated lung cancer triage. For emergency brain imaging, the qER suite automatically interprets non-contrast head CTs to triage neurocritical emergencies like intracranial hemorrhages, midline shifts, and cranial fractures, alongside specialized qER-CTA algorithms designed to detect large vessel occlusions in suspected ischemic stroke patients.

Beyond standard hospital use, Qure.ai is a major infrastructure layer for population-scale health screening and active case-finding in underserved regions. It stands as the first medical imaging artificial intelligence company officially recommended by the World Health Organization for autonomous tuberculosis screening in areas with restricted radiologist access. By integrating with old and new localized X-ray machines alike, the system operates across dozens of countries to run continuous disease surveillance dashboards, track pediatric lung diseases, and deliver rapid digital triage for rural healthcare networks.

The technology is backed by extensive international validation and rigorous regulatory approvals, boasting over 26 distinct clearances from the United States Food and Drug Administration and more than 65 CE-marked indications globally. Its latest solutions include an FDA-approved Predetermined Change Control Plan, ensuring that health systems always utilize the most up-to-date iterations of the diagnostic model as the architecture evolves. To protect sensitive patient data, Qure.ai enforces strict HIPAA and GDPR compliance, structures fully encrypted pipelines, and integrates natively into primary hospital PACS and EHR networks without permanently storing protected health information.